The goal of my research program is to work with knowledge users to inform national and international decisions about optimal infectious disease control and prevention strategies in the context of limited resources, and to provide better modeling tools for policy decisions. My team and I develop state-of-the-art transmission-dynamic models, analyze large population-level datasets, and use epidemiology and health economics to estimate the effectiveness and cost-effectiveness of infectious disease control and prevention strategies at the population-level and within vulnerable or at-risk groups.
Marc Brisson is first author of a new publication in The Lancet: ‘Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study’ [ The Lancet ]
Marc Brisson participated in the EUROGIN International Multidisciplinary HPV Congress held in Vienna, Austria, from March 18 to 21, 2026.
He chaired the following sessions:
He also delivered two oral presentations:
On February 16, 2026, Marc Brisson and Mélanie Drolet organized and led, in collaboration with the Institut national de santé publique du Québec (INSPQ), a knowledge transfer workshop on the mathematical modeling of infectious diseases. Guillaume Gingras also participated in the workshop. Held at INSPQ’s offices in Québec City, the workshop brought together approximately fifteen epidemiologists, public health medical dvisors, and representatives of Québec’s public health authorities.
‘Single-dose HPV vaccination in the United States — a multi-modeling analysis’ [ ScienceDirect ]
Marc Brisson ranked among the World’s Top 2% Scientists of the 2024 Stanford–Elsevier Listing, which groups scientists whose publications has the most impact.